Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape
Biomarkers are widely used at every stage of drug discovery and development. Utilisation of biomarkers has a potential to make drug discovery, development and approval processes more efficient. An overview of the current global regulatory landscape is presented in this article with particular emphas...
Main Authors: | Mariya Gromova, Annegret Vaggelas, Gabriele Dallmann, Diane Seimetz |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/1177271920974652 |
Similar Items
-
From fiction to science: clinical potentials and regulatory considerations of gene editing
by: Maria Schacker, et al.
Published: (2019-10-01) -
Biomarkers of ageing: Current state‐of‐art, challenges, and opportunities
by: Ruiye Chen, et al.
Published: (2023-06-01) -
The Current Landscape of Genetic Testing in Cardiovascular Malformations: Opportunities and Challenges
by: Benjamin John Landis, et al.
Published: (2016-07-01) -
Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations
by: Tim H Ward, et al.
Published: (2022-01-01) -
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges
by: Fan Zhang, et al.
Published: (2022-08-01)